Chronic rhinosinusitis with and without nasal polyps and asthma: Omalizumab improves residual anxiety but not depression.

Vogt, Florian; Sahota, Jagdeep; Bidder, Therese; Livingston, Rebecca; Bellas, Helene; Gane, Simon B; Lund, Valerie J; Robinson, Douglas S; Kariyawasam, Harsha H

Vogt, Florian; Sahota, Jagdeep; Bidder, Therese; Livingston, Rebecca; Bellas, Helene; Gane, Simon B; Lund, Valerie J; Robinson, Douglas S; Kariyawasam, Harsha H.

Afiliação

Vogt F; Department of Respiratory Medicine, University College London Hospital NHS Foundation Trust, London, UK.
Sahota J; Department of Respiratory Medicine, University College London Hospital NHS Foundation Trust, London, UK.
Bidder T; Rhinology UCL Ear Institute, University College London, London, UK.
Livingston R; Department of Respiratory Medicine, University College London Hospital NHS Foundation Trust, London, UK.
Bellas H; Department of Respiratory Medicine, University College London Hospital NHS Foundation Trust, London, UK.
Gane SB; Department of Respiratory Medicine, University College London Hospital NHS Foundation Trust, London, UK.
Lund VJ; Rhinology UCL Ear Institute, University College London, London, UK.
Robinson DS; Rhinology Section, Royal National ENT Hospital, London, UK.
Kariyawasam HH; Rhinology UCL Ear Institute, University College London, London, UK.

Clin Transl Allergy ; 11(1): e12002, 2021 Mar.

Article em En | MEDLINE | ID: mdl-33900051

Palavras-chave

anxiety; asthma; depression; omalizumab; rhinosinusitis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline / Risk_factors_studies Idioma: En Revista: Clin Transl Allergy Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google